Deadline Approaching for Pomdoctor Shareholders in Securities Class Action

Important Shareholder Reminder: Pomdoctor Limited

As a timely reminder, the well-respected law firm Faruqi & Faruqi, LLP is currently investigating potential claims against Pomdoctor Limited, also known simply as Pomdoctor. The firm has drawn attention to the securities class action lawsuit that has been filed against the company, with a significant deadline fast approaching on April 13, 2026.

Faruqi & Faruqi has established itself as a leading national securities law firm and has successfully recovered substantial amounts on behalf of investors since its inception in 1995. Investors who purchased securities from Pomdoctor during the period from October 9, 2025, to December 11, 2025, might have legal options available to them. The firm stresses that anyone interested in participating in this class action should take immediate action, as the deadline is just around the corner.

Allegations Against Pomdoctor

The primary allegations against Pomdoctor involve potential violations of federal securities laws. According to the filed complaint, it is claimed that Pomdoctor and its executives engaged in conduct that misled investors. Some key points raised include:
1. Fraudulent Stock Promotions: Allegations state that Pomdoctor was targeted by a fraudulent stock promotion scheme that involved misinformation disseminated via social media platforms. Some individuals impersonated financial professionals, contributing to the confusion.
2. Insider Trading: There are concerns that insiders or affiliates of Pomdoctor used offshore or nominee accounts to facilitate a coordinated share dump during times of increased stock price, potentially harming other investors.
3. Lack of Disclosure: The complaint indicates that Pomdoctor made public statements that failed to mention the misinformation and the artificial trading activity affecting their stock price, misleading investors about the company’s true position.
4. Share Price Decline: This has culminated in a dramatic decline in Pomdoctor’s stock price, specifically noted to have dropped from approximately $0.50 to $0.38 within a very brief span, representing around a 24% decline in value.

These serious allegations raise substantial questions about the reliability of Pomdoctor’s public communications and overall corporate behavior. Investors are urged to consider the implications of these claims thoroughly.

Actions for Shareholders

For shareholders who are keen to explore their options, Faruqi & Faruqi encourages you to reach out and discuss the situation. The firm recommends that affected shareholders contact them directly through partner Josh Wilson at the numbers provided:

- 877-247-4292 or 212-983-9330 (Ext. 1310)

Furthermore, potential claimants have the opportunity to seek the position of lead plaintiff, which is typically held by the investor with the most significant financial interest at stake. Interested parties must inform the court of their willingness to serve as lead plaintiff through legal counsel or remain involved in the class action as an absent member.

Whistleblowers or individuals with inside knowledge regarding Pomdoctor’s operations and practices are also invited to provide information to the firm, which emphasizes that confidentiality will be maintained.

As deadlines approach, prospective participants in the Pomdoctor class action are urged to act quickly to safeguard their rights and explore restitution options.

To learn additional details about the class action involving Pomdoctor, please visit Faruqi & Faruqi's website or contact advisor Josh Wilson at the numbers provided.

Don't miss this crucial opportunity to secure your legal rights before the impending deadline.